Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients

References

• Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942–955.
   PubMed Web of Science ®Google Scholar
• Martin S, Al Khleifat A, Al-Chalabi A. What causes amyotrophic lateral sclerosis? F1000Res. 2017;6:371.
   PubMedGoogle Scholar
• Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997–1006.
   PubMed Web of Science ®Google Scholar
• Jin XF, Wu N, Wang L, et al. Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing Central nervous system diseases. Cell Mol Neurobiol. 2013;33(5):601–613.
   PubMed Web of Science ®Google Scholar
• Joilin G, Leigh PN, Newbury SF, et al. An overview of microRNAs as biomarkers of ALS. Front Neurol. 2019;10:186.
   PubMed Web of Science ®Google Scholar
• de Andrade HM, de Albuquerque M, Avansini SHdSRC, et al. MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J Neurol Sci. 2016;368:19–24.
   PubMed Web of Science ®Google Scholar
• Joilin G, Gray E, Thompson AG, et al. Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis. Brain Commun. 2020;2(1):fcaa053.
   PubMedGoogle Scholar
• Toivonen JM, Manzano R, Olivan S, et al. MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS One. 2014;9(2):e89065.
   PubMed Web of Science ®Google Scholar
• Waller R, Goodall EF, Milo M, et al. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS). Neurobiol Aging. 2017;55:123–131.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Yoshioka Y, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010;285(23):17442–17452.
   PubMed Web of Science ®Google Scholar
• Matsuda A, Yan IK, Foye C, et al. MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2016;30(5):577–590.
   PubMed Web of Science ®Google Scholar
• Thompson AG, Gray E, Heman-Ackah SM, et al. 2016. Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers. Nat Rev Neurol. 12:346–357.
   PubMed Web of Science ®Google Scholar
• Thompson AG, Gray E, Mager I, et al. UFLC-derived CSF extracellular vesicle origin and proteome. Proteomics. 2018;18(24):e1800257.
   PubMed Web of Science ®Google Scholar
• Saint-Pol J, Gosselet F, Duban-Deweer S, et al. Targeting and crossing the blood-brain barrier with extracellular vesicles. Cells. 2020;9(4):851.
   PubMed Web of Science ®Google Scholar
• Waller R, Wyles M, Heath PR, et al. Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front Neurosci. 2017;11:731.
   PubMed Web of Science ®Google Scholar
• Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17(1):3.
   Google Scholar
• Langmead B, Trapnell C, Pop M, et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3):R25.
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
   PubMed Web of Science ®Google Scholar
• Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and Colon cancer data sets. Cancer Res. 2004;64(15):5245–5250.
   PubMed Web of Science ®Google Scholar
• Williams AH, Valdez G, Moresi V, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326(5959):1549–1554.
   PubMed Web of Science ®Google Scholar
• Matsuzaka Y, Kishi S, Aoki Y, et al. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for limb-girdle muscular dystrophy, facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy. Environ Health Prev Med. 2014;19(6):452–458.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang J, He J, et al. Serum miRNAs miR-23a, 206, and 499 as potential biomarkers for skeletal muscle atrophy. Biomed Res Int. 2017;2017:8361237.
   PubMed Web of Science ®Google Scholar
• Varcianna A, Myszczynska MA, Castelli LM, et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626–635.
   PubMed Web of Science ®Google Scholar
• Fernandez-Messina L, Gutierrez-Vazquez C, Rivas-Garcia E, et al. Immunomodulatory role of microRNAs transferred by extracellular vesicles. Biol Cell. 2015;107(3):61–77.
   PubMed Web of Science ®Google Scholar
• Pawar K, Shigematsu M, Sharbati S, et al. Infection-induced 5'-half molecules of tRNAHisGUG activate Toll-like receptor 7. PLoS Biol. 2020;18(12):e3000982.
   PubMed Web of Science ®Google Scholar
• Prada I, Gabrielli M, Turola E, et al. Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations. Acta Neuropathol. 2018;135(4):529–550.
   PubMed Web of Science ®Google Scholar
• Ren W, Hou J, Yang C, et al. Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery. J Exp Clin Cancer Res. 2019;38(1):62.
   PubMed Web of Science ®Google Scholar